Clinical Trial Update: Endometrial Cancer - LOHP Alone and With 5FU [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating LOHP alone and in combination with 5-FU in endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• LOHP

Snippet

Sponsor: Sanofi | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED